Immix Biopharma, Inc. IMMX Number of Exercisable Options
Number of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s number of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s number of exercisable options?
- Immix Biopharma, Inc. (IMMX) reported number of exercisable options of 3.4M in Q1 2026.
- How has Immix Biopharma, Inc.'s number of exercisable options changed year-over-year?
- Immix Biopharma, Inc.'s number of exercisable options increased by 1088.8% year-over-year, from 289.1K to 3.4M.
- What is the long-term trend for Immix Biopharma, Inc.'s number of exercisable options?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s number of exercisable options has grown at a 31.2% compound annual growth rate (CAGR), from 1.1M to 3.2M.
- What does number of exercisable options mean?
- The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.